Homology-directed repair (HDR) enables precise genome editing; however, its application in mammalian cells is limited by low efficiency due to competition from error-prone repair pathways and intrinsically restricted HDR activity. Existing HDR-enhancement strategies, including small-molecule treatments and marker-based selection, are constrained by cytotoxicity, genomic scarring, and inconsistent performance. Here, we present ESS-HDR (essential gene-supported scarless HDR), a robust, drug- and marker-free platform that selectively enriches HDR-proficient cells. By leveraging essential-gene coediting, ESS-HDR enables precise and scarless genome modification with enhanced efficiency. CRISPR-Cas9 induces double-strand breaks at both the target locus and an essential gene, accompanied by two donor templates: one introducing the desired edit and the other restoring essential-gene function. Only cells that undergo accurate HDR at the essential locus survive, providing endogenous selection without exogenous markers. Single-cell clone analysis confirms that enrichment of HDR-proficient cells enhances editing at the target locus. Using ssODN donors carrying a 1-nt substitution or a 10-nt insertion, ESS-HDR increases HDR efficiencies by 7-16-fold in HEK293 cells and 41-fold in primary epidermal keratinocytes compared to conventional single-site HDR. With plasmid donors targeting,, or, ESS-HDR improves knock-in efficiencies by 6-34-fold across HEK293, U2OS, and HeLa cells. ESS-HDR also outperforms chemical enhancers including RS-1, SCR7, nocodazole, and AZD7648. Together, these findings establish ESS-HDR as a broadly applicable strategy for efficient, scarless genome editing without external selection markers. TUBA1B LMNB1ACTB1
CRISPR Gene Editing